Bosentan
NDC 68180-340, Bosentan, tablet, for suspension, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-340
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213154
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BOSENTAN32 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-340-13 | 68180034013 | 4 BLISTER PACK in 1 CARTON (68180-340-13) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/540b6f6a-79f3-4681-8c2a-268cf7cecbc9
Use it
Look up 68180-340 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.